Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.58 |
| ▸ | GSK3B | P49841 | 2/20 | 0.58 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.57 |
| ▸ | WNT3A | P56704 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL719034 | 0.88 | NR4A2 (0.85) | NR4A2MAPTL3MBTL1LMNATDP1 | |
| SCHEMBL30121738 | 0.88 | NR4A2 (0.85) | NR4A2MAPTL3MBTL1LMNATDP1 | |
| SCHEMBL7889843 | 0.87 | TDP1 (0.76) | NR4A2MAPTL3MBTL1LMNATDP1 | |
| SCHEMBL4055319 | 0.87 | TDP1 (0.69) | NR4A2MAPTL3MBTL1LMNATDP1 | |
| SCHEMBL4476891 | 0.84 | NR4A2 (0.65) | NR4A2MAPTL3MBTL1LMNATDP1 | |
| SCHEMBL7290443 | 0.83 | NR4A2 (0.63) | NR4A2MAPTL3MBTL1LMNATDP1 | |
| SCHEMBL8982046 | 0.82 | KMT2A (0.45) | NR4A2MAPTL3MBTL1LMNATDP1 | |
| SCHEMBL27945874 | 0.81 | ALDH1A1 (0.87) | NR4A2MAPTL3MBTL1LMNATDP1 | |
| SCHEMBL354105 | 0.81 | NR4A2 (1.00) | NR4A2MAPTL3MBTL1LMNATDP1 | |
| SCHEMBL28372673 | 0.80 | L3MBTL1 (0.72) | NR4A2MAPTL3MBTL1LMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10693073-B2 | Fullerene derivatives and organic electronic device comprising fullerene derivatives | LG CHEM, LTD. (KR) | 2020-06-23 | — | — | US | disclosed |
| EP-3093270-A1 | FULLERENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE COMPRISING FULLERENE DERIVATIVES | LG Chem, Ltd. (KR) | 2016-11-16 | — | — | EP | disclosed |
| US-20160329498-A1 | FULLERENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE COMPRISING FULLERENE DERIVATIVES | LG CHEM, LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| US-5608015-A | Processes for producing cyclodextrin derivatives and polymers containing immobilized cyclodextrin therein | TOPPAN PRINTING CO., LTD. (JP) | 1997-03-04 | — | — | US | disclosed |
| US-4400511-A | 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10693073-B2 | Fullerene derivatives and organic electronic device comprising fullerene derivatives | MDM4, OR10J3, ANXA2 | NR4A2 1484/4885MAPT 1120/4885L3MBTL1 2714/4885 |
| US-20160329498-A1 | FULLERENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE COMPRISING FULLERENE DERIVATIVES | MDM4, OR10J3, ANXA2 | NR4A2 1484/4885MAPT 1120/4885L3MBTL1 2714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.